XML 39 R32.htm IDEA: XBRL DOCUMENT v3.25.4
Schedule II. Condensed Financial Information of Registrant
12 Months Ended
Dec. 31, 2025
Condensed Financial Information Disclosure [Abstract]  
Schedule II. Condensed Financial Information of Registrant

Schedule II. Condensed Financial Information of Registrant

AMERISAFE, INC.

CONDENSED BALANCE SHEETS

 

 

December 31,

 

 

 

2025

 

 

2024

 

 

 

(in thousands)

 

Assets:

 

 

 

 

 

 

Investments:

 

 

 

 

 

 

Fixed maturity securities—available-for-sale, at fair value
   (amortized cost $
997 and $4,988 in 2025 and 2024, respectively)

 

$

970

 

 

$

4,925

 

Equity securities, at fair value (cost $0, and $5,110 in 2025
   and 2024, respectively)

 

 

 

 

 

8,000

 

Short-term investments

 

 

4,593

 

 

 

 

Investment in subsidiaries

 

 

220,923

 

 

 

230,936

 

Total investments

 

 

226,486

 

 

 

243,861

 

Cash and cash equivalents

 

 

19,946

 

 

 

11,793

 

Deferred income taxes

 

 

1,240

 

 

 

685

 

Notes receivable from subsidiaries

 

 

2,398

 

 

 

2,007

 

Property and equipment, net

 

 

1,311

 

 

 

762

 

Federal income tax recoverable

 

 

3,252

 

 

 

1,676

 

Other assets

 

 

1,261

 

 

 

1,051

 

Total assets

 

$

255,894

 

 

$

261,835

 

Liabilities and shareholders’ equity

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

Accounts payable and other liabilities

 

 

4,296

 

 

 

4,494

 

Total liabilities

 

 

4,296

 

 

 

4,494

 

Shareholders' equity (net of Treasury stock of $54,155 and $42,052
   at December 31, 2025 and 2024, respectively)

 

 

251,598

 

 

 

257,341

 

Total liabilities and shareholders' equity

 

$

255,894

 

 

$

261,835

 

Schedule II. Condensed Financial Information of Registrant – (Continued)

AMERISAFE, INC.

CONDENSED STATEMENTS OF INCOME

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Revenues

 

 

 

 

 

 

 

 

 

Net investment income

 

$

3,593

 

 

$

2,279

 

 

$

4,861

 

Net unrealized gains (losses) on equity securities

 

 

(2,890

)

 

 

141

 

 

 

(845

)

Fee and other income

 

 

8,856

 

 

 

10,395

 

 

 

8,933

 

Total revenues

 

 

9,559

 

 

 

12,815

 

 

 

12,949

 

Expenses

 

 

 

 

 

 

 

 

 

Other operating costs

 

 

8,856

 

 

 

10,395

 

 

 

8,932

 

Total expenses

 

 

8,856

 

 

 

10,395

 

 

 

8,932

 

Income before income taxes and equity in earnings of subsidiaries

 

 

703

 

 

 

2,420

 

 

 

4,017

 

Income tax expense

 

 

617

 

 

 

1,412

 

 

 

1,055

 

Gain before equity in earnings of subsidiaries

 

 

86

 

 

 

1,008

 

 

 

2,962

 

Equity in net income of subsidiaries

 

 

47,058

 

 

 

54,428

 

 

 

59,146

 

Net income

 

$

47,144

 

 

$

55,436

 

 

$

62,108

 

Schedule II. Condensed Financial Information of Registrant – (Continued)

AMERISAFE, INC.

CONDENSED STATEMENTS OF CASH FLOWS

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Operating activities

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

$

554

 

 

$

2,623

 

 

$

5,591

 

Investing activities

 

 

 

 

 

 

 

 

 

Purchases of investments

 

 

(4,588

)

 

 

 

 

 

(24,885

)

Proceeds from sales of investments

 

 

12,223

 

 

 

22,502

 

 

 

35,013

 

Purchases of property and equipment

 

 

(1,124

)

 

 

231

 

 

 

(482

)

Dividends from subsidiary

 

 

62,700

 

 

 

71,000

 

 

 

56,000

 

Net cash provided by investing activities

 

 

69,211

 

 

 

93,733

 

 

 

65,646

 

Financing activities

 

 

 

 

 

 

 

 

 

Finance lease purchases

 

 

(85

)

 

 

(85

)

 

 

(91

)

Share-based compensation related tax withholding

 

 

(817

)

 

 

(554

)

 

 

(944

)

Purchase of treasury stock

 

 

(12,103

)

 

 

(5,123

)

 

 

(2,171

)

Dividends to shareholders

 

 

(48,607

)

 

 

(85,436

)

 

 

(93,307

)

Net cash used in financing activities

 

 

(61,612

)

 

 

(91,198

)

 

 

(96,513

)

Change in cash and cash equivalents

 

 

8,153

 

 

 

5,158

 

 

 

(25,276

)

Cash and cash equivalents at beginning of year

 

 

11,793

 

 

 

6,635

 

 

 

31,911

 

Cash and cash equivalents at end of year

 

$

19,946

 

 

$

11,793

 

 

$

6,635